Location History:
- Shelburne, CA (2008 - 2011)
- Ontario, CA (2011)
Company Filing History:
3 out of 4,945 
2 out of 33 
1 out of 53 Years Active: 2008-2011
Title: Fortunata McConkey: Innovator in Cancer Treatment
Introduction
Fortunata McConkey is a notable inventor based in Shelburne, CA, recognized for his significant contributions to the field of cancer treatment. With a total of five patents to his name, McConkey has focused on developing innovative solutions for the diagnosis and treatment of cancerous diseases.
Latest Patents
One of McConkey's latest patents is centered on the cytotoxicity mediation of cells that exhibit surface expression of CD44. This invention is crucial for the staging, diagnosis, and treatment of cancerous diseases, including both primary tumors and tumor metastases. It particularly emphasizes the use of cancerous disease modifying antibodies (CDMAB), which can be combined with various chemotherapeutic agents to initiate a cytotoxic response. Additionally, the invention includes binding assays that utilize the CDMAB, enhancing the effectiveness of anti-cancer treatments.
Career Highlights
Throughout his career, Fortunata McConkey has worked with prominent companies such as Hoffmann-La Roche Inc. and Arius Research, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
McConkey has collaborated with esteemed colleagues, including David S. F. Young and Susan E. Hahn, who have played significant roles in his research endeavors.
Conclusion
Fortunata McConkey's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in cancer therapy, showcasing the importance of innovation in healthcare.